"Hims' Super Bowl ad does not promote a specific drug or medication and therefore is not required to provide information about side effects or risks," Brunner said in a statement. "Instead, it encouraged viewers to consult with a healthcare provider, which aligns with the FTC's guidelines for non-specific, 'help-seeking' advertisements."
Hims & Hers began offering compounded semaglutide through its platform in May after launching a new weight loss program in late 2023. Semaglutide is the active ingredient in Ozempic and Wegovy, which can each cost around $1,000 a month without insurance.